1-3 of 3
Simon Dujardin
Close
Sort by
Journal Articles

CBL , CBLB , TET2 , ASXL1 , and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

e-blood
Hideki Makishima, Anna M. Jankowska, Michael A. McDevitt, Christine O'Keefe, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Harish Siddaiah, Mohammed Shaik, Hadrian Szpurka, Eric Hsi, Anjali Advani, Ronald Paquette, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2011) 117 (21): e198–e206.
https://doi.org/10.1182/blood-2010-06-292433
Published: 2011
Includes: Supplemental data
Journal Articles

SNP-A Karyotyping Provides Clinically Relevant Results In Myeloid Hematologic Disorders with Unsuccessful Routine Cytogenetic Testing.

Kathryn M Guinta, Hideki Makishima, MD, PhD, Christine L. O'Keefe, PhD, Simon Dujardin, Ramon V. Tiu, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P Maciejewski, MD, PhD, FACP
Journal: Blood
Blood (2010) 116 (21): 3374.
https://doi.org/10.1182/blood.V116.21.3374.3374
Published: 2010
Journal Articles

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Hideki Makishima, MD, PhD, Anna Jankowska, MSC, Michael A McDevitt, MD, PhD, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Siddaiah Harish, MD, Mohammed Shaik, MD, Eric Hsi, MD, Anjali Advani, MD, Ronald Paquette, MD, Jaroslaw P Maciejewski, MD, PhD, FACP
Journal: Blood
Blood (2010) 116 (21): 3396.
https://doi.org/10.1182/blood.V116.21.3396.3396
Published: 2010